14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGIO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

On Tuesday, Agios Pharmaceuticals stock price gained an impressive 5.30%
(Updated on Apr 23, 2024)

Buy candidate since Apr 22, 2024 Gain 5.30% PDF

The Agios Pharmaceuticals stock price gained 5.30% on the last trading day (Tuesday, 23rd Apr 2024), rising from $30.21 to $31.81. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 8.62% from a day low at $30.40 to a day high of $33.02. The price has risen in 7 of the last 10 days and is up by 7.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 401 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $38.96 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.42% during the next 3 months and, with a 90% probability hold a price between $33.22 and $46.31 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGIO Signals & Forecast

The Agios Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $29.72 and $29.72. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -8.62%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Agios Pharmaceuticals stock

Agios Pharmaceuticals finds support from accumulated volume at $31.79 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.62 between high and low, or 8.62%. For the last week, the stock has had daily average volatility of 4.66%.

Our recommended stop-loss: $30.02 (-5.62%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 39 days ago.)

Trading Expectations (AGIO) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Agios Pharmaceuticals to open at $31.74, and during the day (based on 14 day Average True Range), to move between $30.53 and $33.09, which gives a possible trading interval of +/-$1.28 (+/-4.01%) up or down from last closing price. If Agios Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $31.79 (0.06%) than the resistance at $32.87 (3.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Agios Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals stock to perform well in the short-term.

Current score: 3.630 Buy Candidate Unchanged

Predicted Opening Price for Agios Pharmaceuticals of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$31.74 ( 0.210%) $31.81

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 34.36 8.03 %
R2 33.36 4.88 %
R1 32.74 2.94 %
Current price: 31.81
Support S1 30.74 -3.36 %
S2 30.12 -5.30 %
S3 29.12 -8.45 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 34.81 9.43 %
R2 32.99 3.71 %
R1 32.87 3.33 %
Current price 31.81
Support S1 31.79 -0.0629%
S2 29.94 -5.88%
S3 26.80 -15.75%

FAQ

What is the symbol for Agios Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Agios Pharmaceuticals is AGIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agios Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals stock to perform well in the short-term.

How to buy Agios Pharmaceuticals Stock?
Agios Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agios Pharmaceuticals Stock.

What's the current price of Agios Pharmaceuticals Stock?
As of the end of day on the Apr 23, 2024, the price of an Agios Pharmaceuticals (AGIO) share was $31.81.

What is the 52-week high and low for Agios Pharmaceuticals Stock?
The 52-week high for Agios Pharmaceuticals Stock is $35.48 and the 52-week low is $19.80.

What is the market capitalization of Agios Pharmaceuticals Stock?
As of the Apr 23, 2024, the market capitalization of Agios Pharmaceuticals is 1.679B.

When is the next earnings date for Agios Pharmaceuticals?
The upcoming earnings date for Agios Pharmaceuticals is May 02, 2024.
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT